Distrust, Race, and Research

University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Archives of Internal Medicine (Impact Factor: 17.33). 11/2002; 162(21):2458-63. DOI: 10.1001/archinte.162.21.2458
Source: PubMed


Investigators have voiced concerns that distrust of research and the medical community impedes successful recruitment of African Americans into clinical research.
To examine possible differences in distrust by race and to determine to what extent other sociodemographic factors explain any racial differences in distrust.
We analyzed data from 527 African American and 382 white respondents of a national telephone survey on participation in clinical research. Our main outcome measure was a 7-item index of distrust.
African American respondents were more likely than white respondents not to trust that their physicians would fully explain research participation (41.7% vs 23.4%, P<.01) and to state that they believed their physicians exposed them to unnecessary risks (45.5% vs 34.8%, P<.01). African American respondents had a significantly higher mean distrust index score than white respondents (3.1 vs 1.8, P<.01). After controlling for other sociodemographic variables in a logistic regression model, race remained strongly associated with a higher distrust score (prevalence odds ratio, 4.7; 95% confidence interval, 2.9-7.7).
Even after controlling for markers of social class, African Americans were less trusting than white Americans. Racial differences in distrust have important implications for investigators as they engage African Americans in research.

Download full-text


Available from: Stephen B Thomas, Oct 30, 2015
  • Source
    • "Our findings of ‘concern with experimentation’ and ‘travel difficulty’ as barriers to participation are similar to a recent meta-analysis by Mills et al. [21]. Non-white people, especially African Americans were significantly more likely than white people to cite concern with experimentation as a barrier, which indicates discomfort with the experimentation process [42,43]. This may be due to historical research abuses of blacks and the persistence of health inequities experienced by racial minorities [34,42,43]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: As breast cancer patients increasingly use complementary and alternative medicine (CAM), clinical trials are needed to guide appropriate clinical use. We sought to identify socio-demographic, clinical and psychological factors related to willingness to participate (WTP) and to determine barriers to participation in an acupuncture clinical trial among breast cancer patients. We conducted a cross-sectional survey study among post-menopausal women with stage I-III breast cancer on aromatase inhibitors at an urban academic cancer center. Of the 300 participants (92% response rate), 148 (49.8%) reported WTP in an acupuncture clinical trial. Higher education (p = 0.001), increased acupuncture expectancy (p < 0.001), and previous radiation therapy (p = 0.004) were significantly associated with WTP. Travel difficulty (p = 0.002), concern with experimentation (p = 0.013), and lack of interest in acupuncture (p < 0.001) were significant barriers to WTP. Barriers differed significantly by socio-demographic factors with white people more likely to endorse travel difficulty (p = 0.018) and non-white people more likely to concern with experimentation (p = 0.024). Older patients and those with lower education were more likely to report concern with experimentation and lack of interest in acupuncture (p < 0.05). Although nearly half of the respondents reported WTP, significant barriers to participation exist and differ among subgroups. Research addressing these barriers is needed to ensure effective accrual and improve the representation of individuals from diverse backgrounds.
    BMC Complementary and Alternative Medicine 01/2014; 14(1):7. DOI:10.1186/1472-6882-14-7 · 2.02 Impact Factor
  • Source
    • "These disparities are even greater among the undocumented population. Giselle Corbie-Smith, MD, and her colleagues found that African Americans were “more likely to believe that their physicians would not explain research fully or would treat them as part of an experiment without their consent” [11]. Medical abuses have come to light through the oral tradition of minority groups and published reports. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The foreign-born population in the United States, according to the "Current Populations Report" published in 2010, is estimated to exceed 39.9 million, or "12.9 percent of the U.S. population." The increase in foreign-born peoples and their need for health care is a complicated issue facing many cities, health systems and hospitals. Over the course of the past few years Mercy Hospital of Philadelphia has treated increasing numbers of foreign-born African patients. The majority have been presenting in the late stages of disease. The increase of foreign-born documented and undocumented African patients seen by Mercy Hospitals seems to reflect a foreign-born population "boom" in Philadelphia over the past decade. To meet the needs of this growing population, the Mercy Hospital Task Force on African Immigration and the Institute of Catholic Bioethics at Saint Joseph's University designed a program that centers on the third world concept of "Health Promoters." This program is intended to serve as one possible solution for hospitals to cost-effectively manage the care of this growing percentage of foreign-born individuals in the population. This notion of a "Health Promoter" program in Philadelphia is unique as one of those rare occasions when a third world concept is being utilized in a first world environment. It is also unique in that it can serve as a paradigm for other hospitals in the United States to meet the growing need of health care for the undocumented population. As of November 2012 the Mercy Hospital of Philadelphia clinic became operative for patients who were referred from the Health Promoter clinics. To date, a total of forty-two patients have actively participated in the screenings, sixteen of which have been referred to Mercy Hospital of Philadelphia clinic for further evaluation. More than 75% of patient referrals were a result of high blood pressure. According to the American Medical Association, readings of 140-159 mmHg and above are indicative of stage 1 hypertension. Among those who presented at the Health Promoter screenings the mean systolic pressure for males was 140 mmHg and for females was 140.48 mmHg.
    Medical science monitor: international medical journal of experimental and clinical research 10/2013; 19(1):807-817. DOI:10.12659/MSM.889651 · 1.43 Impact Factor
  • Source
    • "Moreover, Black RDDTS samples are 60–70% female, and hence may contain too few Black men for reliable population estimates of Black men’s smoking (2–4). Blacks’ high non-response rate (low research participation) is widely understood as a function of distrust of researchers, and dissatisfaction with their failure to improve health in the Black communities they study (11). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: This study tested the hypothesis that data from random digit-dial telephone surveys underestimate the prevalence of cigarette smoking among African-American adults. Method: A novel, community-sampling method was used to obtain a statewide, random sample of N = 2118 California (CA) African-American/Black adults, surveyed door-to-door. This Black community sample was compared to the Blacks in the CA Health Interview Survey (N = 2315), a statewide, random digit-dial telephone survey conducted simultaneously. Results: Smoking prevalence was significantly higher among community (33%) than among telephone survey (19%) Blacks, even after controlling for sample differences in demographics. Conclusion: Telephone surveys underestimate smoking among African-Americans and probably underestimate other health risk behaviors as well. Alternative methods are needed to obtain accurate data on African-American health behaviors and on the magnitude of racial disparities in them.
    Frontiers in Public Health 09/2013; 1. DOI:10.3389/fpubh.2013.00036
Show more